Inhibition of HSP90 reduces the expression of senescence-associated inflammatory factors in senescent cancer cells [36] and extends the lifespan of Ercc1-defficient progeroid mice by inducing senescence cell apoptosis [28]. Here, HSP90AB1 is linked to cancer.